A partir de cette page vous pouvez :
|Retourner au premier écran avec les dernières notices...|
Détail de l'auteur
Documents disponibles écrits par cet auteurAjouter le résultat dans votre panier Affiner la recherche
10 years of surveillance of human tularaemia in France / Mailles A in Eurosurveillance [Euro Surveill], Vol. 19, N° 45 ([13/11/2014])
Titre : 10 years of surveillance of human tularaemia in France Type de document : Article scientifique Auteur(s) : Mailles A ; Vaillant V Appartenance auteur(s) InVS DMI Année de publication : 2014 Article en page(s) : pii=20956 Langues : Anglais (eng)
in Eurosurveillance [Euro Surveill] > Vol. 19, N° 45 [13/11/2014] . - pii=20956
Mots-clés : Tularémie ; Surveillance épidémiologique ; France Résumé : Tularaemia has been mandatorily notifiable in France since October 2002. The surveillance aims to detect early any infection possibly due to bioterrorism and to follow up disease trends. We report the results of national surveillance from 2002 to 2012. A case is defined as a patient with clinical presentation suggestive of tularaemia and biological confirmation of infection or an epidemiological link with a biologically confirmed case. Clinical, biological and epidemiological data are collected using a standardised notification form. From 2002 to 2012, 433 cases were notified, with a median age of 49 years (range 2 to 95 years) and a male female sex ratio of 1.8. Most frequent clinical presentations were glandular tularaemia (n=200; 46%) and ulceroglandular tularaemia (n=113; 26%). Most frequent at-risk exposures were handling hares (n=179; 41%) and outdoor leisure exposure to dust aerosols (n=217; 50%). Tick bites were reported by 82 patients (19%). Ten clusters (39 cases) were detected over the 10-year period, as well as a national outbreak during winter 2007/2008. The tularaemia surveillance system is able to detect small clusters as well as major outbreaks. Surveillance data show exposure to dust aerosols during outdoor leisure activities to be a major source of contamination in France. PMID Pubmed : Pubmed : 25411688 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=12603[article]A 2-year study on cytomegalovirus infection during pregnancy in a French hospital / Picone O in British Journal of Obstetrics and Gynaecology [BJOG], Vol. 116, N° 6 (05/2009)
Titre : A 2-year study on cytomegalovirus infection during pregnancy in a French hospital Type de document : Article scientifique Auteur(s) : Picone O ; Vauloup Fellous C ; Cordier AG ; Parent du Chatelet I ; Senat MV ; Frydman R ; Grangeot Keros L Appartenance auteur(s) InVS DMI Année de publication : 2009 Article en page(s) : 818-23 Langues : Anglais (eng)
in British Journal of Obstetrics and Gynaecology [BJOG] > Vol. 116, N° 6 (05/2009) . - 818-23
Mots-clés : Cytomégalovirus ; Grossesse ; Gestation [pathologie] ; Transmission verticale ; Nouveau né ; Diagnostic prénatal ; Dépistage anténatal ; France Résumé : OBJECTIVES: To evaluate the proportion of pregnant women agreeing to cytomegalovirus (CMV) serologic screening. To collect data on CMV infection during pregnancy. DESIGN: Prospective study. SETTING: During two years, all pregnant women were informed on CMV infection. If the patient agreed, serological testing was performed around 12 weeks of gestation (WG) and, if negative, redone around 36 WG. POPULATION: Four thousand two hundred and eighty-seven pregnant women followed from 12 weeks to delivery. METHODS: If the first CMV serologic test was negative, detailed hygiene information was given to the parents. Diagnosis of primary infection was based on the detection of CMV-G, CMV-M and low CMV-G avidity index. When maternal infection was confirmed, diagnosis of CMV congenital infection was done in the newborns by urine culture within the three days following birth. Crude infection-rate data consisted of the number of CMV infection cases and person-time units for both exposed to hygiene CMV information (12 to 36 WG) and unexposed pregnant women (first 12 WG). MAIN OUTCOME MEASURES: Rate of CMV seropositive and seronegative women. Rate of women agreeing for screening. Rate of primary infection. Rate of seroconversion. Number of CMV-infected newborns. RESULTS: Among the 4287 women followed, 3792 were either seronegative or with an unknown immune status. 96.7% out of them agreed for screening. 53.2% were initially CMV-specific IgG negative. Primary infection was detected in nine women between 0 and 12 WG (0.46%) and seroconversion was diagnosed in five women between 12 and 36 WG (0.26%) (mid P = 0.02, 95% CI [1.07-13.6]). CONCLUSIONS: If clear information on CMV infection during pregnancy is given, patients frequently agree to screening. The rate of seroconversion after information, observed in this study, is low after counselling.(R.A.) PMID Pubmed : Pubmed : 19432571 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=1366[article]2009 pandemic influenza A(H1N1) outbreak in a complex of schools in Paris, France, June 2009 / Carrillo Santisteve P in Eurosurveillance [Euro Surveill], Vol. 15, N° 25 (24/06/2010)
Titre : 2009 pandemic influenza A(H1N1) outbreak in a complex of schools in Paris, France, June 2009 Type de document : Article scientifique Auteur(s) : Carrillo Santisteve P ; Renard Dubois S ; Cheron G ; Csaszar Goutchkoff M ; Lecuit M ; Lortholary O ; Bello PY Appartenance auteur(s) InVS DMI ; Cire Ile-de-France Champagne-Ardenne Année de publication : 2010 Article en page(s) : pii=19599 Langues : Anglais (eng)
in Eurosurveillance [Euro Surveill] > Vol. 15, N° 25 (24/06/2010) . - pii=19599
Mots-clés : Nouvelle grippe A (H1N1) ; Epidémie ; Ecole ; Enfant ; Taux attaque ; Fermeture ; Paris Résumé : An outbreak of 2009 pandemic influenza A(H1N1), involving 81 cases with symptoms of influenza-like illness, was confirmed in June 2009 in a complex of schools in Paris, France. At that time, there was no community transmission in France. The index case, a 10-year-old girl, had travelled to the United Kingdom with her school class. Of the 81 symptomatic cases, 35 were confirmed and 46 were probable; 48 of the cases were female. Three were adults and 78 were children (median age of the children was 7.9 years, range: 6 months to 12 years). Control measures were implemented as soon as a new case was confirmed in a school, which included active case finding among the pupils in the same class as the index case, setting up a dedicated influenza outpatient clinic that families were recommended to consult if necessary, prophylactic treatment of contacts and school closure. A retrospective study was conducted on all confirmed cases and all symptomatic cases who had consulted the dedicated outpatient clinic from 17 to 27 June 2009. Further work is needed to better define conditions under which the pandemic virus can be transmitted in schools and in households. (R.A.) PMID Pubmed : Pubmed : 20587360 Corpus : CIRE/Grippe A(H1N1)/Production scientifique InVS Lien(s) externe(s) : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19599 Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=632[article]
10324_PSAdobe Acrobat PDF
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals / Rondy M in Eurosurveillance [Euro Surveill], Vol. 20, N° 2 ([15/01/2015])
Titre : 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals Type de document : Article scientifique Auteur(s) : Rondy M ; Launay O ; Puig Barbera J ; Gefenaite G ; Castilla J ; de Gaetano Donati K ; Galtier F ; Hak E ; Guevara M ; Costanzo S ; European hospital IVE network ; Moren A Appartenance auteur(s) InVS DMI Année de publication : 2015 Article en page(s) : pii: 21011 Langues : Anglais (eng)
in Eurosurveillance [Euro Surveill] > Vol. 20, N° 2 [15/01/2015] . - pii: 21011
Mots-clés : Grippe ; Vaccin ; Efficacité ; Hôpital ; Europe Résumé : While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted a multicentre test-negative case control study to estimate IVE against hospitalised laboratory-confirmed influenza in the target population in 18 hospitals in France, Italy, Lithuania and the Navarre and Valencia regions in Spain. All hospitalised patients aged ≥18 years, belonging to the target population presenting with influenza-like illness symptom onset within seven days were swabbed. Patients positive by reverse transcription polymerase chain reaction for influenza virus were cases and those negative were controls. Using logistic regression, we calculated IVE for each influenza virus subtype and adjusted it for month of symptom onset, study site, age and chronic conditions. Of the 1,972 patients included, 116 were positive for influenza A(H1N1)pdm09, 58 for A(H3N2) and 232 for influenza B. Adjusted IVE was 21.3% (95% confidence interval (CI): -25.2 to 50.6; n=1,628), 61.8% (95% CI: 26.8 to 80.0; n=557) and 43.1% (95% CI: 21.2 to 58.9; n=1,526) against influenza A(H1N1)pdm09, A(H3N2) and B respectively. Our results suggest that the 2012/13 IVE was moderate against influenza A(H3N2) and B and low against influenza A(H1N1)pdm09. PMID Pubmed : Pubmed : 25613779 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=12593[article]2014 French guidelines for hepatitis B and C screening. A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV / Bottero J in Liver international [Liver Int.], In Press ([01/04/2016])
Titre : 2014 French guidelines for hepatitis B and C screening. A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV Type de document : Article scientifique Auteur(s) : Bottero J ; Brouard C ; Roudot Thoraval F ; Deuffic Burban S ; Hofliger P ; Abergel A ; Volant J ; Dhumeaux D ; Yazdanpanah Y ; Viral Hepatitis Testing Experts group Appartenance auteur(s) InVS DMI Année de publication : 2016 Article en page(s) : 8 p. Langues : Anglais (eng)
in Liver international [Liver Int.] > In Press [01/04/2016] . - 8 p.
Mots-clés : VHB ; VHC ; Dépistage ; France Résumé : Background & Aims: worldwide and, to a lesser extent, in France, a minority of individuals infected with hepatitis B (HBV) and C (HCV) is aware of its status. Given the current availability of highly effective anti-HBV and anti-HCV agents, the high rate of undiagnosed people, associated with individual and community prejudices (liver disease worsening, persistence of a hidden transmission reservoir and medicoeconomic burden of delayed care), is unacceptable.
Methods: on the occasion of the first French general report on viral hepatitis, new recommendations for HBV and HCV testing were issued. We aim to introduce the new French strategy for HBV and HCV screening, and to describe the underlying epidemiological data.
Results: these recommendations comprise various items. First, the screening of chronic viruses, namely HBV, HCV and HIV, should be quasi-systematically combined. Second, the targeted screening of groups at risk of viral exposure must be strengthened. Third, routine testing for each of these three viruses should be offered at least once to men of 18 60 years old who had never been tested. In parallel, in pregnant women, in addition to HIV HBV screening, currently recommended HCV testing should be routinely performed during the first trimester of pregnancy. In order to best achieve the target populations, community initiatives that propose testing actions should be encouraged, particularly those including rapid point-of-care tests.
Conclusions: overall, these recommendations aim to define a comprehensive testing strategy for chronic viral infections, emphasizing both targeted screening and mass screening and considering jointly HBV, HCV and HIV.
PMID Pubmed : Pubmed : 27043826 Lien externe DOI : DOI : 10.1111/liv.13135 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=12924[article]2ème journée régionale de veille sanitaire en région Rhône-Alpes / Melihan Cheinin P
PermalinkAbsence of infection in asymptomatic contacts of index SARS case in France / Le Vu S in Eurosurveillance. European communicable disease quarterly [Euro Surveill (quaterly)], Vol. 11, N° 1-3 (03/2006)
PermalinkAcceptabilité et faisabilité du dépistage systématique du VIH dans 27 services d'urgences d'Île-de-France (ANRS 95008 et Sidaction), mai 2009-août 2010. Numéro thématique. L'infection à VIH-sida en France en 2009 : dépistage, nouveaux diagnostics et incidence / Cremieux AC in Bulletin Epidémiologique Hebdomadaire [Bull Epidemiol Hebd], N° 45-46 (30/11/2010)
PermalinkAccès au don du sang des hommes ayant des relations sexuelles avec des hommes et impact sur le risque de transmission du VIH par transfusion : tour d’horizon international / Pillonel J in Transfusion clinique et biologique [Transfus Clin Biol], Vol. 18, N° 2 (04/2011)
PermalinkAccès tardif aux soins, précarité et vulnérabilité des femmes séropositives / Calvez M in Médecine sciences [Med Sci], Vol. 24, N° HS 2 (03/2008)
PermalinkLes accidents d'exposition au sang chez les sages-femmes dans les maternités françaises. Résultats de la surveillance nationale en 2003 / Vincent A in Journal de gynécologie, obstétrique et biologie de la reproduction [J Gynecol Obstet Biol Reprod], Vol. 35, N° 3 (05/2006)
PermalinkAcquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013 / Ruppe E in Eurosurveillance [Euro Surveill], Vol. 19, N° 14 ([10/04/2014])
PermalinkActes du 2e séminaire Maladies Infectieuses Emergentes. Actualités et propositions / Che D ; Séminaire Maladies Infectieuses Emergentes (7 décembre 2012; Ecole du Val-de-Grâce, Paris)
PermalinkActes de colloque "Surveillance et prévention des infections nosocomiales. 10 ans du raisin" / Institut de veille sanitaire
PermalinkActive case finding for tuberculosis among high-risk groups in low-incidence countries / Zenner D in The international journal of tuberculosis and lung disease [Int J Tuberc Lung Dis], Vol. 17, N° 5 ([01/05/2013])